Santé log2h
AssureCare Welcomes Stacy Mountain as Vice President of Sales
CINCINNATI, Sept. 30, 2024 (GLOBE NEWSWIRE) -- AssureCare, a leading provider of Population Health Management solutions, is ...
Santé log2h
Instinct Report: Morale is Trending Up in 2024, but Employee Turnover Remains High in ER & Specialty Hospitals
PHILADELPHIA, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Instinct Science, a leading technology provider for veterinary hospitals, today announced its second annual State of Emergency and Specialty Veterinary ...
Santé log2h
MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS)
MediciNova holds Orphan Drug Designation for MN-166 (ibudilast) in ALS by U.S. FDA and EU EMA. MN-166 (ibudilast) has received Fast Track Designation by FDA for treatment of ALS. In addition, MN-166 ...
Santé log2h
Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference
Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, ...
Santé log2h
Clene Announces $7.3 Million Registered Direct Offering and Concurrent Private Placements Priced at Market Under Nasdaq Rules
Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly-owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial ...
Santé log2h
Parexel Earns Prestigious Society for Clinical Research Sites Eagle Award for Second Consecutive Year
Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced it has been awarded the 2024 Society ...
Santé log1h
SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome Treatment
FDA confirms that SciSparc’s study may proceed only a month after application submission . TEL AVIV, Israel, Sept. 30, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Co ...
Santé log1h
Sonnet BioTherapeutics Announces Launch of CEO Corner Platform
The first segment of the CEO Corner is now accessible on the Company’s website here. Segments on the CEO Corner platform will be accessible on the Company’s website ( www.sonnetbio.com) for 90 days.
Santé log1h
UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
ResMed’s new AI-enabled health concierge, Dawn, is changing how people learn about sleep apnea. Dawn provides instant, 24/7 access to many answers about sleep health, ResMed products, and CPAP therapy ...
Santé log1h
AIM ImmunoTech Announces Pricing of $1.26 Million Registered Direct Offering
The gross proceeds to the Company from the registered direct offering and concurrent private placement are estimated to be approximately $1.26 million before deducting the placement agent’s fees and ...
Santé log2h
FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa
Event: 2024 Cell & Gene Meeting on the Mesa Session Date and Time: October 7, 2024, at 5:45 p.m. MST Location: FLW Ballroom F For more information, please visit FibroBiologics' website or email ...
Santé log23h
Cytokinetics Presents Additional Data From SEQUOIA-HCM at the HFSA Annual Scientific Meeting
SOUTH SAN FRANCISCO, Calif., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that additional analyses synthesizing data from SEQUOIA-HCM (Safety, Efficacy, ...